IRCT201211062106N4已完成2 期
Effectiveness of Itraconazole on clinical symptoms and radiologic findings in patients with recurrent chronic rhinosinusitis and nasal polyposis
Isfahan University of Medical Sciences, Vice Challenry0 个研究点目标入组 22 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 22
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 15 years 至 no limit（—）
- 性别
- All
入选标准
- •The inclusion criteria contained patients at least 15 years old without history of hepatic disease and heart failure; without allergy to Itraconazole, and usage of interacting medications (cisapride, dofetilide, ergot derivatives, levomethadyl lovastatin, midazolam (oral), nisoldipine, pimozide, quinidine, simvastatin, or triazolam). Exclusion criteria of the study were no compliance for follow up; side effects of Itraconazole like rising in hepatic enzyme; nausea, vomiting or starting a new treatment during the study.
排除标准
- 未提供
研究者
相似试验
尚未招募
不适用
comparitive study of two antifungal medicines in treatment of superficial fungal infectioCTRI/2018/07/015063IMS BH
尚未招募
3 期
Efficacy and safety of itraconazole, SUBA-itraconazole and voriconazole in Recalcitrant Dermatophytosis.CTRI/2024/05/066681I
尚未招募
不适用
To compare the effectiveness of oral itraconazole with low dose and high dose isotretinoin in the treatment of tineaCTRI/2019/06/019600Department of dermatology
尚未招募
3 期
A comparative study between oral itraconazole and terbinafine in tinea infectioCTRI/2023/10/058844Mahatma Gandhi Hospital
进行中（未招募）
1 期
Itraconazole as treatment for severe nose bleeding in patients with hereditary hemorrhagic telangiectasiaSevere epistaxis in patients with Hereditary Hemorrhagic Telangiectasia also known as Rendu-Osler-Weber diseaseMedDRA version: 20.0Level: LLTClassification code 10031132Term: Osler-Weber-Rendu diseaseSystem Organ Class: 100000004850MedDRA version: 20.0Level: LLTClassification code 10038554Term: Rendu-Osler-Weber syndromeSystem Organ Class: 100000004850EUCTR2017-003272-31-NLSt. Antonius Ziekenhuis25